Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
View Scopus Profile
Li Qin
Principal Research Scientist
Lymphoma-Myeloma
https://orcid.org/0000-0003-0099-4992
h-index
1861
Citations
22
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2003
2024
Research activity per year
Overview
Fingerprint
Network
Research output
(32)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Li Qin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Nuclear Receptor Coactivator 1
100%
Breast Neoplasms
86%
Nuclear Receptor Coactivator 3
63%
Neoplasm Metastasis
51%
Neoplasms
35%
Integrins
35%
Trophoblasts
31%
Tubal Pregnancy
27%
Cell Movement
22%
Triple Negative Breast Neoplasms
21%
Human Mammary Glands
20%
Matrix Metalloproteinase 2
19%
Mothers
19%
Transcription Factors
18%
Estrogen Receptors
17%
TNF Receptor-Associated Factor 4
16%
Cell Adhesion
16%
3(17)-hydroxysteroid dehydrogenase
16%
Steroid Receptors
16%
Transcription Factor AP-1
16%
phospholipase D2
15%
Matrix Metalloproteinase 14
15%
Nuclear Receptor Subfamily 4, Group A, Member 1
15%
Mi-2 Nucleosome Remodeling and Deacetylase Complex
14%
bufalin
14%
Proteins
14%
Extracellular Matrix Proteins
14%
Growth
14%
SERPIN-B5
14%
Prostatic Neoplasms
14%
Carcinogenesis
13%
Epithelial Cells
12%
Histone Demethylases
12%
link protein
12%
Pregnancy
11%
Cell Proliferation
11%
Genes
11%
Tissue Inhibitor of Metalloproteinases
11%
Phosphatidic Acids
11%
Extracellular Matrix
11%
Aromatase
10%
Matrix Metalloproteinase Inhibitors
10%
Clustered Regularly Interspaced Short Palindromic Repeats
10%
Prodrugs
9%
Castration
9%
Telomere
9%
Oncogenes
9%
Ubiquitination
9%
Long Noncoding RNA
9%
Ligands
9%
Agriculture & Biology
steroid receptors
40%
breast neoplasms
31%
neoplasms
17%
dropouts
13%
cardiomyopathy
12%
phosphatidylinositol 3-kinase
11%
cardiomyocytes
10%
prognosis
10%
neoplasm cells
10%
mice
10%
lethal genes
8%
phenotype
5%
genomics
5%
genome
5%
